Biocompatible fabrics are materials chosen for skin-contact medical devices. Biocompatibility itself belongs to the finished device and is assessed through a risk-based evaluation under the ISO 10993 series. A fabric is a candidate when it tolerates skin contact, survives cleaning or sterilization, and has no known sensitizers such as latex or neoprene. Until the device is evaluated, treat biocompatible materials as candidates.
A print that calls for “biocompatible fabric” and nothing else is not a specification. The term has no single material definition, so the first thing we do with that print is write back and ask what touches the patient, where, and for how long.
This post is meant to save that round trip. We write it from a facility that sews antimicrobial fabric and technical laminates into medical device components. Fieldtex Cases is FDA-registered and ISO 9001:2015 certified.
Key takeaways
- Biocompatibility is judged on the finished device in its real contact conditions. A fabric on its own never earns the label.
- Contact type and duration set the depth of the evaluation. A strap on intact skin is not assessed like an implant.
- “Medical grade fabric” has no single regulatory definition. It tells you which market a supplier is aiming at.
- Latex allergy and sensitivity to some neoprene products are reasons to specify a neoprene-free material for skin-contact parts.
What Does “Biocompatible” Mean for a Medical Device Fabric?
In medical device manufacturing, biocompatibility means the body does not react badly to a material in the way the device uses it. That makes it a conclusion about a device and its use, not a label a fabric arrives with. The same knit can suit a strap on intact skin and be wrong for a wound or mucosal application. What the device touches, and for how long, decides how much evidence it needs.
The fabric is only part of what touches the patient. Dyes, finishes, coatings, adhesives, thread, and processing residues can all end up on or near the skin, and the sewing process sits in that chain too. Picture a strap that sits on a forearm for a full shift. The knit, the dye, the thread, and the hook-and-loop may all touch that skin, so biocompatibility cannot be judged at the fabric level alone.
If your print says only “biocompatible,” add the contact site and the wear time before it goes out.
How Is Biocompatibility Assessed Under ISO 10993?
Biocompatibility is assessed under the ISO 10993 series, a risk-based framework for the biological evaluation of medical devices. How deep the evaluation goes depends on what the device touches and for how long.
Start with contact type. The current edition, ISO 10993-1:2025, sorts devices by the tissue they touch, from intact skin through mucosal membranes and breached surfaces to internal tissue and circulating blood.
Next, look at contact duration. FDA’s contact-duration definitions set limited contact at up to 24 hours, prolonged contact at more than 24 hours up to 30 days, and long-term or permanent contact at more than 30 days. The more invasive the contact and the longer it lasts, the more evidence the evaluation calls for.
Last, check the endpoints, which are the specific biological effects to evaluate. For a component on intact skin, cytotoxicity (damage to cells), sensitization (allergic reaction), and irritation are the ones commonly considered, and duration, materials, and device-specific risks can add others.
FDA’s September 2023 guidance on using ISO 10993-1 also describes cases where existing information and a documented rationale can cover certain intact-skin devices without new testing. It is not a blanket exemption, and it depends on the device, its materials and its use.
| Contact category | Typical example | Evaluation considerations |
|---|---|---|
| Intact skin | Strap, sleeve, wearable enclosure | Cytotoxicity, sensitization, and irritation are commonly considered; duration, materials, and device-specific risks can add others |
| Intact mucosal membrane | Mucosal-contact textile | Greater biological exposure than intact skin; the evaluation depends on duration |
| Breached surface, internal tissue or circulating blood | Wound-dressing-type textile; deeper contact is beyond a sewn component | More extensive, device-specific evaluation; outside the focus of this post |
The device manufacturer owns the biological safety evaluation and the regulatory file. That company runs or commissions the evaluation, and a contract sewing supplier supports it with controlled processes and accurate material, manufacturing, and traceability records. Our page on ISO 13485 sewing support covers how the wider quality system fits around it.
Which Fabrics Are Used in Skin-Contact Medical Devices?
Several material families go into skin-contact medical device components, and each one is a candidate material. None is biocompatible until the finished device has been evaluated.
Start with antimicrobial fabric. It carries a treatment or fiber that limits microbial growth on the material. It does not make a device sterile, and it does not show infection prevention or patient safety. A claim that goes beyond protecting the fabric itself can bring a treated fabric under EPA pesticide registration rules (FIFRA).
Next come technical laminates and coated fabrics, which we use where a barrier or a wipe-down surface is needed. Needle holes break a barrier, so we settle seam placement and sealing at the same time as the material. Cleaning matters as much as the cloth, since repeated wipe-down with hospital disinfectants wears some finishes down. Our material selection guidance lists what we stock.
What makes a fabric breathable enough for prolonged skin contact?
Moisture vapor transmission rate is one important measure of breathability, meaning how fast water vapor passes through the material. Over a long wear period, a strap or sleeve that holds moisture against the skin is uncomfortable and can irritate. Open knits and breathable constructions move vapor better than coated or laminated cloth, and the trade-off appears when a part also needs a barrier.
Choose medical breathable materials together with the construction of the part, because a laminated seam behaves differently from an open knit.
Why are neoprene-free materials specified?
Some neoprene products have been linked to allergic skin reactions in susceptible wearers, as case reports on neoprene orthopedic supports show, and natural rubber latex allergy is a separate sensitivity. Some designers of patient-contact components specify a neoprene-free alternative from the start for that reason.
A neoprene-free medical fabric may take one potential sensitizer off the list, though it does not remove every allergy risk or replace the evaluation of the finished device.
Send us a skin-contact component for a material and construction review before tooling starts. Our medical wearables manufacturing team looks at fabric, seams, and cleaning needs together.
What Can a Contract Sewing Supplier Certify, and What Can’t It?
A contract sewing supplier can show what it built, with which materials, and from which lot. It cannot say a finished device is biocompatible, because that conclusion comes from the device maker’s own safety evaluation.
We supply lot traceability from incoming material through cutting, sewing, and shipment, plus material identification for each lot and certificates of conformance. We do not run biocompatibility testing, and we make no claims about whether a device is safe.
Here is where we stand on quality:
- Fieldtex Cases holds ISO 9001:2015 certification and manufactures to ISO 13485 documentation and process standards. Fieldtex Cases is not ISO 13485 certified.
- Our facility is FDA-registered, which means it is listed with the FDA. Registration does not mean the FDA has approved or cleared a device.
Our medical sewing services page explains the controls we use on the parts we build.
Once you know where our responsibility ends, your quality team can manage us as an approved supplier in its own system. We can tell you which material lot went into unit 400 of your build. We cannot tell you your device is biocompatible. That is your evaluation, and any supplier who offers to do it for you is overreaching.
Biocompatible Fabric FAQs
What makes a fabric biocompatible?
Biocompatibility is assessed on the finished device under the ISO 10993 series, so a fabric is a candidate rather than biocompatible in itself. A fabric that tolerates skin contact and carries no known sensitizers is a reasonable starting point for the device manufacturer’s evaluation.
Is antimicrobial fabric the same as biocompatible fabric?
No. Antimicrobial treatment limits microbial growth on the material, while biocompatibility asks whether the patient’s body reacts badly to the device. A fabric can have one property without the other, and an antimicrobial claim does not replace the device’s biological evaluation.
What does “medical grade fabric” actually mean?
Medical-grade fabric has no single regulatory definition. The phrase describes a supplier’s intended market and documentation practice, such as traceability and consistent finishing. It is not a certified status.
Can you supply biocompatibility documentation for a sewn component?
We supply material identification, lot traceability, and certificates of conformance for the parts we build. Biological evaluation stays with the device manufacturer and sits in its risk management file. We can provide the material information that the evaluation draws on.
What Should a Print Say Instead of “Biocompatible”?
Name the contact type and duration on the print instead of the word “biocompatible,” and the material conversation becomes workable. Intact skin, several hours of wear, and a daily wipe-down give us enough to talk through antimicrobial fabric and construction against real conditions, and they give your team traceable inputs for its own evaluation. Talk to us about a skin-contact component, or request a quote. We return quotes within 48 hours.
This article gives general information about material selection and biological evaluation. It does not determine whether a particular device or component is biocompatible, suitable for a specific patient-contact use, or compliant with regulatory requirements. The device manufacturer remains responsible for the device-specific evaluation and regulatory file.
Sources
- ISO 10993-1:2025 – Biological evaluation of medical devices — Part 1: Requirements and general principles for the evaluation of biological safety within a risk management process
- Biocompatibility Evaluation Endpoints by Contact Duration Periods | FDA
- Important Reminders about Registration and Listing | FDA
- FIFRA Compliance: Five Tips for Antimicrobial Apparel Manufacturers and Distributors
- ISO 13485:2016 – Medical devices — Quality management systems — Requirements for regulatory purposes
